Rina Na, W. Luan, Yinzai He, Yanwei Gao, Nier Cha, Baoqin Jia
{"title":"肺腺癌中表皮生长因子受体(EGFR)分子变化与间变性淋巴瘤激酶(ALK)突变的关系","authors":"Rina Na, W. Luan, Yinzai He, Yanwei Gao, Nier Cha, Baoqin Jia","doi":"10.1007/s10330-020-0440-0","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":345149,"journal":{"name":"Oncology and Translational Medicine","volume":"39 42","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Relationship between molecular changes in epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) mutations in lung adenocarcinoma\",\"authors\":\"Rina Na, W. Luan, Yinzai He, Yanwei Gao, Nier Cha, Baoqin Jia\",\"doi\":\"10.1007/s10330-020-0440-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":345149,\"journal\":{\"name\":\"Oncology and Translational Medicine\",\"volume\":\"39 42\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oncology and Translational Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s10330-020-0440-0\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology and Translational Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s10330-020-0440-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Relationship between molecular changes in epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) mutations in lung adenocarcinoma